Latest Avoro Capital Advisors LLC Stock Portfolio
$11.14Billion | No. of Holdings #26
Avoro Capital Advisors LLC Performance
2026 Q2+17.32%
YTD+22.04%
2025+47.90%
About Avoro Capital Advisors LLC and 13F Hedge Fund Stock Holdings
Avoro Capital Advisors LLC is a hedge fund based in New York, NY. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Avoro Capital Advisors LLC reported an equity portfolio of $11.1 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Avoro Capital Advisors LLC are UTHR, , KRYS. The fund has invested 13.5% of it's portfolio in UNITED THERAPEUTICS CORP and 12.2% of portfolio in ASCENDIS PHARMA. <br><br> The fund managers got completely rid off ASCENDIS PHARMA (ASND), APELLIS PHARMACEUTICALS INC (APLS) and CENTESSA PHARMACEUTICALS PLC (CNTA) stocks. They significantly reduced their stock positions in LEXEO THERAPEUTICS INC, VERA THERAPEUTICS INC (VERA) and REVOLUTION MEDICINES INC (RVMD). Avoro Capital Advisors LLC opened new stock positions in ASCENDIS PHARMA and FAETH THERAPEUTICS INC (SNSE). The fund showed a lot of confidence in some stocks as they added substantially to VIRIDIAN THERAPEUTICS INC (VRDN), AVALO THERAPEUTICS (AVTX) and CYTOKINETICS INC (CYTK).
Avoro Capital Advisors LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$11.14Billion
as of Aug 14, 2026Avoro Capital Advisors LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Avoro Capital Advisors LLC made a return of 17.32% in the last quarter. In trailing 12 months, it's portfolio return was 93.68%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| ascendis pharma | 1,363,240,000 |
| hemab therapeutics hldgs inc | 70,710,800 |
| faeth therapeutics inc | 36,101,000 |
New stocks bought by Avoro Capital Advisors LLC
Additions
| Ticker | % Inc. |
|---|---|
| viridian therapeutics inc | 66.67 |
| avalo therapeutics | 65.48 |
| cytokinetics inc | 50.00 |
| definium therapeutics inc | 43.78 |
| uniqure nv | 12.89 |
| taysha gene therapies inc | 10.09 |
| arrowhead pharmaceuticals inc | 6.13 |
| united therapeutics corp | 5.62 |
Additions to existing portfolio by Avoro Capital Advisors LLC
Reductions
| Ticker | % Reduced |
|---|---|
| lexeo therapeutics inc | -20.58 |
| vera therapeutics inc | -2.8 |
| revolution medicines inc | -2.02 |
Avoro Capital Advisors LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| apellis pharmaceuticals inc | -491,700,000 |
| centessa pharmaceuticals plc | -454,018,000 |
| terns pharmaceuticals inc | -300,240,000 |
| ascendis pharma | -1,157,950,000 |
| soleno therapeutics inc | -77,004,000 |
| mannkind corp | -5,390,000 |
| alkermes plc | -42,432,000 |
Avoro Capital Advisors LLC got rid off the above stocks
Sector Distribution
Avoro Capital Advisors LLC has about 71.7% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 71.7 |
| Others | 28.3 |
Market Cap. Distribution
Avoro Capital Advisors LLC has about 44.2% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- UNALLOCATED
- MID-CAP
- SMALL-CAP
| Category | % |
|---|---|
| LARGE-CAP | 44.2 |
| UNALLOCATED | 28.3 |
| MID-CAP | 23.2 |
| SMALL-CAP | 3.8 |
Stocks belong to which Index?
About 49.2% of the stocks held by Avoro Capital Advisors LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 50.8 |
| RUSSELL 2000 | 49.2 |
Avoro Capital Advisors LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Avoro Capital Advisors LLC
Avoro Capital Advisors LLC has 26 stocks in it's portfolio. About 79.5% of the portfolio is in top 10 stocks. UTHR proved to be the most loss making stock for the portfolio. KRYS was the most profitable stock for Avoro Capital Advisors LLC last quarter.
$11.14BTotal Value
33.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Whitehawk Therapeutics Inc Avoro Capital Advisors LLC's holding in Whitehawk Therapeutics Inc over time | 0.12% | 2,849,400 | $13.05M 0.12% | 0%unchanged 0 percentunchanged | |
 Alkermes Plc Alkermes PlcALKS Avoro Capital Advisors LLC's holding in Alkermes Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Apellis Pharmaceuticals Inc Avoro Capital Advisors LLC's holding in Apellis Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 ARGX Argenx SeArgenx SeARGX | 8.33% | 1,000,000 | $927.77M 8.33% | 0%unchanged 0 percentunchanged | |
 Arrowhead Pharmaceuticals Inc Avoro Capital Advisors LLC's holding in Arrowhead Pharmaceuticals Inc over time | 8.31% | 11,355,600 | $925.59M 8.31% | 6.13%increased 6.13 percentadded | |
 ASND Ascendis PharmaAscendis PharmaASND | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Avalo Therapeutics Avoro Capital Advisors LLC's holding in Avalo Therapeutics over time | 0.39% | 2,333,330 | $43.12M 0.39% | 65.48%increased 65.48 percentadded | |
 Celcuity Inc Celcuity IncCELC Avoro Capital Advisors LLC's holding in Celcuity Inc over time | 3.19% | 3,400,000 | $355.71M 3.19% | 0.74%increased 0.74 percentadded | |
 Centessa Pharmaceuticals Plc Avoro Capital Advisors LLC's holding in Centessa Pharmaceuticals Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Cytokinetics Inc Cytokinetics IncCYTK Avoro Capital Advisors LLC's holding in Cytokinetics Inc over time | 3.83% | 5,000,000 | $425.95M 3.83% | 50%increased 50 percentadded | |
 GHRS Gh Research PlcGh Research PlcGHRS | 0.43% | 1,800,000 | $48.38M 0.43% | 0%unchanged 0 percentunchanged | |
 Damora Therapeutics Inc Avoro Capital Advisors LLC's holding in Damora Therapeutics Inc over time | 0.88% | 3,783,000 | $98.40M 0.88% | 0%unchanged 0 percentunchanged | |
 Krystal Biotech Inc Avoro Capital Advisors LLC's holding in Krystal Biotech Inc over time | 9.64% | 2,888,890 | $1.07B 9.64% | 0%unchanged 0 percentunchanged | |
 Kymera Therapeutics Inc Avoro Capital Advisors LLC's holding in Kymera Therapeutics Inc over time | 7.7% | 7,474,750 | $857.13M 7.7% | 0%unchanged 0 percentunchanged | |
 Madrigal Pharmaceuticals Inc Avoro Capital Advisors LLC's holding in Madrigal Pharmaceuticals Inc over time | 8.84% | 1,833,330 | $984.41M 8.84% | 0.83%increased 0.83 percentadded | |
 Mannkind Corp Mannkind CorpMNKD Avoro Capital Advisors LLC's holding in Mannkind Corp over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Ocular Therapeutix Inc Avoro Capital Advisors LLC's holding in Ocular Therapeutix Inc over time | 1.11% | 12,540,000 | $123.14M 1.11% | 1.83%increased 1.83 percentadded | |
 Uniqure Nv Uniqure NvQURE Avoro Capital Advisors LLC's holding in Uniqure Nv over time | 2.78% | 6,727,780 | $309.88M 2.78% | 12.89%increased 12.89 percentadded | |
 Revolution Medicines Inc Avoro Capital Advisors LLC's holding in Revolution Medicines Inc over time | 3.86% | 2,297,000 | $430.18M 3.86% | 2.02%decreased 2.02 percentreduced | |
 Soleno Therapeutics Inc Avoro Capital Advisors LLC's holding in Soleno Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |